Results from pediatric patients in the SAVE Registry shows no device-related adverse events or immunosuppression and continued strong survival ...

Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS), a clinical-stage biopharmaceutical company specializing in the development ...

Repatha is the Only PCSK9 Inhibitor to Significantly Reduce the Risk of First CV Events in High-Risk Primary Prevention VESALIUS-CV Subgroup Findings Reinforce Benefit ...

At the movies, the Third Reich and the Republican Party seem to converge if you squint.

Part of the reason women’s hair loss remains difficult to talk about is that it does not always fit into a simple, familiar pattern. Hair loss in women can be linked to genetics, hormonal changes, ...